カテゴリー： Transparency Market Research, 世界, 医療/バイオ

生体吸収性血管足場の世界市場2023～2031：製品別

◆英語タイトル：Bioresorbable Vascular Scaffold Market (Product Type: Everolimus-eluting Device, Novolimus-eluting Device, Sirolimus-eluting Device, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23JUL078）◆商品コード：TMR23JUL078
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年5月
◆ページ数：228
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の当調査レポートでは、世界の生体吸収性血管足場市場規模が、2023年の161.5百万ドルから2031年までに316.7百万ドルに拡大し、予測期間中に年平均（CAGR）7.8%で成長すると推測しています。本書は、生体吸収性血管足場の世界市場について詳しく調査し、市場状況及び展望についてまとめています。序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別（エベロリムス溶出装置、ノボリムス溶出装置、シロリムス溶出装置、その他）分析、疾患別（冠動脈疾患、末梢血管疾患）分析、材料別（ポリ-L-乳酸、チロシン由来ポリカーボネート、その他）分析、エンドユーザー別（病院、外来手術センター、心臓カテーテル研究室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、中南米）分析、競争状況など、以下の構成で掲載しています。また、市場参入企業として、Kyoto Medical Planning Co., Ltd.、BIOTRONIK Group of Companies.、REVA Medical、Elixir Medical、Arterius、Meril Life Sciences Pvt. Ltd.、S3V Vascular Technologies、Zorion Medicalなどを含んでいます。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・世界の生体吸収性血管足場市場規模：製品別
- エベロリムス溶出装置の市場規模
- ノボリムス溶出装置の市場規模
- シロリムス溶出装置の市場規模
- その他製品の市場規模
・世界の生体吸収性血管足場市場規模：疾患別
- 冠動脈疾患における市場規模
- 末梢血管疾患における市場規模
・世界の生体吸収性血管足場市場規模：材料別
- ポリ-L-乳酸における市場規模
- チロシン由来ポリカーボネートにおける市場規模
- その他材料における市場規模
・世界の生体吸収性血管足場市場規模：エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- 心臓カテーテル研究室における市場規模
- その他エンドユーザーにおける市場規模
・世界の生体吸収性血管足場市場規模：地域別
- 北米の生体吸収性血管足場市場規模
- ヨーロッパの生体吸収性血管足場市場規模
- アジア太平洋の生体吸収性血管足場市場規模
- 中東・アフリカの生体吸収性血管足場市場規模
- 中南米の生体吸収性血管足場市場規模
・競争状況

Bioresorbable Vascular Scaffold Market – Scope of Report
TMR’s report on the global Bioresorbable Vascular Scaffold market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Bioresorbable Vascular Scaffold market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Bioresorbable Vascular Scaffold market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Bioresorbable Vascular Scaffold market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Bioresorbable Vascular Scaffold market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Bioresorbable Vascular Scaffold market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Bioresorbable Vascular Scaffold market.

The report delves into the competitive landscape of the global Bioresorbable Vascular Scaffold market. Key players operating in the global Bioresorbable Vascular Scaffold market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Bioresorbable Vascular Scaffold market profiled in this report.

Key Questions Answered in Global Bioresorbable Vascular Scaffold Market Report
• What is the sales/revenue generated by Bioresorbable Vascular Scaffold across all regions during the forecast period?
• What are the opportunities in the global Bioresorbable Vascular Scaffold market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Bioresorbable Vascular Scaffold Market – Research Objectives and Research Approach
The comprehensive report on the global Bioresorbable Vascular Scaffold market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Bioresorbable Vascular Scaffold market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Bioresorbable Vascular Scaffold market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioresorbable Vascular Scaffold Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Development
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, 2017 – 2031
5. Key Insights
    5.1. Technological Advancement
    5.2. Disease Incidence and Prevalence
    5.3. Regulatory Analysis
    5.4. COVID-19 Impact Analysis
6. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017 – 2031
        6.3.1. Everolimus-eluting Device
        6.3.2. Novolimus-eluting Device
        6.3.3. Sirolimus-eluting Device
        6.3.4. Others (Rapamycin, etc.)
    6.4. Market Attractiveness Analysis, By Product Type
7. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Disease Type
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Disease Type, 2017 – 2031
        7.3.1. Coronary Artery Disease
        7.3.2. Peripheral Artery Disease
    7.4. Market Attractiveness Analysis, By Disease Type
8. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Material Type
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Material Type, 2017 – 2031
        8.3.1. Poly-L-Lactic Acid (PLLA)
        8.3.2. Tyrosine-derived Polycarbonate
        8.3.3. Others (Polydioxanone, etc.)
    8.4. Market Attractiveness Analysis, By Material Type
9. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast, by End-user, 2017 – 2031
        9.3.1. Hospital
        9.3.2. Ambulatory Surgical Center
        9.3.3. Cardiac Catheterization Lab
        9.3.4. Others (Research Institute, etc.)
    9.4. Market Attractiveness Analysis, By End-user
10. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness Analysis, By Region
11. North America Bioresorbable Vascular Scaffold Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017 – 2031
        11.2.1. Everolimus-eluting Device
        11.2.2. Novolimus-eluting Device
        11.2.3. Sirolimus-eluting Device
        11.2.4. Others (Rapamycin, etc.)
    11.3. Market Value Forecast, by Disease Type, 2017 – 2031
        11.3.1. Coronary Artery Disease
        11.3.2. Peripheral Artery Disease
    11.4. Market Value Forecast, by Material Type, 2017 – 2031
        11.4.1. Poly-L-Lactic Acid (PLLA)
        11.4.2. Tyrosine-derived Polycarbonate
        11.4.3. Others (Polydioxanone, etc.)
    11.5. Market Value Forecast, by End-user, 2017 – 2031
        11.5.1. Hospital
        11.5.2. Ambulatory Surgical Center
        11.5.3. Cardiac Catheterization Lab
        11.5.4. Others (Research Institute, etc.)
    11.6. Market Value Forecast, by Country, 2017 – 2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Product Type
        11.7.2. By Disease Type
        11.7.3. By Material Type
        11.7.4. By End-user
        11.7.5. By Country
12. Europe Bioresorbable Vascular Scaffold Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017 – 2031
        12.2.1. Everolimus-eluting Device
        12.2.2. Novolimus-eluting Device
        12.2.3. Sirolimus-eluting Device
        12.2.4. Others (Rapamycin, etc.)
    12.3. Market Value Forecast, by Disease Type, 2017 – 2031
        12.3.1. Coronary Artery Disease
        12.3.2. Peripheral Artery Disease
    12.4. Market Value Forecast, by Material Type, 2017 – 2031
        12.4.1. Poly-L-Lactic Acid (PLLA)
        12.4.2. Tyrosine-derived Polycarbonate
        12.4.3. Others (Polydioxanone, etc.)
    12.5. Market Value Forecast, by End-user, 2017 – 2031
        12.5.1. Hospital
        12.5.2. Ambulatory Surgical Center
        12.5.3. Cardiac Catheterization Lab
        12.5.4. Others (Research Institute, etc.)
    12.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Spain
        12.6.5. Italy
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Product Type
        12.7.2. By Disease Type
        12.7.3. By Material Type
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific Bioresorbable Vascular Scaffold Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017 – 2031
        13.2.1. Everolimus-eluting Device
        13.2.2. Novolimus-eluting Device
        13.2.3. Sirolimus-eluting Device
        13.2.4. Others (Rapamycin, etc.)
    13.3. Market Value Forecast, by Disease Type, 2017 – 2031
        13.3.1. Coronary Artery Disease
        13.3.2. Peripheral Artery Disease
    13.4. Market Value Forecast, by Material Type, 2017 – 2031
        13.4.1. Poly-L-Lactic Acid (PLLA)
        13.4.2. Tyrosine-derived Polycarbonate
        13.4.3. Others (Polydioxanone, etc.)
    13.5. Market Value Forecast, by End-user, 2017 – 2031
        13.5.1. Hospital
        13.5.2. Ambulatory Surgical Center
        13.5.3. Cardiac Catheterization Lab
        13.5.4. Others (Research Institute, etc.)
    13.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Product Type
        13.7.2. By Disease Type
        13.7.3. By Material Type
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America Bioresorbable Vascular Scaffold Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017 – 2031
        14.2.1. Everolimus-eluting Device
        14.2.2. Novolimus-eluting Device
        14.2.3. Sirolimus-eluting Device
        14.2.4. Others (Rapamycin, etc.)
    14.3. Market Value Forecast, by Disease Type, 2017 – 2031
        14.3.1. Coronary Artery Disease
        14.3.2. Peripheral Artery Disease
    14.4. Market Value Forecast, by Material Type, 2017 – 2031
        14.4.1. Poly-L-Lactic Acid (PLLA)
        14.4.2. Tyrosine-derived Polycarbonate
        14.4.3. Others (Polydioxanone, etc.)
    14.5. Market Value Forecast, by End-user, 2017 – 2031
        14.5.1. Hospital
        14.5.2. Ambulatory Surgical Center
        14.5.3. Cardiac Catheterization Lab
        14.5.4. Others (Research Institute, etc.)
    14.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Product Type
        14.7.2. By Disease Type
        14.7.3. By Material Type
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa Bioresorbable Vascular Scaffold Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Product Type, 2017 – 2031
        15.2.1. Everolimus-eluting Device
        15.2.2. Novolimus-eluting Device
        15.2.3. Sirolimus-eluting Device
        15.2.4. Others (Rapamycin, etc.)
    15.3. Market Value Forecast, by Disease Type, 2017 – 2031
        15.3.1. Coronary Artery Disease
        15.3.2. Peripheral Artery Disease
    15.4. Market Value Forecast, by Material Type, 2017 – 2031
        15.4.1. Poly-L-Lactic Acid (PLLA)
        15.4.2. Tyrosine-derived Polycarbonate
        15.4.3. Others (Polydioxanone, etc.)
    15.5. Market Value Forecast, by End-user, 2017 – 2031
        15.5.1. Hospital
        15.5.2. Ambulatory Surgical Center
        15.5.3. Cardiac Catheterization Lab
        15.5.4. Others (Research Institute, etc.)
    15.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Product Type
        15.7.2. By Disease Type
        15.7.3. By Material Type
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player – Competition Matrix (By Tier and Size of companies)
    16.2. Market Share Analysis By Company (2021)
    16.3. Company Profiles
        16.3.1. Kyoto Medical Planning Co., Ltd.
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Test Type Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. BIOTRONIK Group of Companies
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Test Type Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. REVA Medical
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Test Type Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Elixir Medical
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Test Type Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Arterius
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Test Type Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Meril Life Sciences Pvt. Ltd
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Test Type Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. S3V Vascular Technologies
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Test Type Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Zorion medical
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Test Type Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Medtronic (development phase)
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Test Type Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview

List of Tables

Table 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 02: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031

Table 03: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031

Table 04: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 05: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 06: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 07: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 08: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031

Table 09: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031

Table 10: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 11: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 12: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 13: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031

Table 14: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031

Table 15: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 16: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 17: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 18: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031

Table 19: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031

Table 20: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 21: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 23: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031

Table 24: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031

Table 25: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 26: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 27: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031

Table 28: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031

Table 29: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031

Table 30: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 生体吸収性血管足場の世界市場2023～2031：製品別(Bioresorbable Vascular Scaffold Market (Product Type: Everolimus-eluting Device, Novolimus-eluting Device, Sirolimus-eluting Device, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 薬剤溶出バルーンの世界市場2023-2031：産業分析、規模、シェア、成長、動向、予測
  • 冠動脈疾患用薬剤溶出バルーンの世界市場見通し2023年-2029年
  • 世界の巣状分節性糸球体硬化症市場2023-2031：疾患別（原発性巣状分節性糸球体硬化症、続発性巣状分節性糸球体硬化症）、疾患管理別（診断、治療）

    • ◆H&Iグローバルリサーチのお客様（例）◆